NCT04971018View on ClinicalTrials.gov

Impact of Transcutaneous Auricular Vagus Nerve Stimulation on Digestive Symptoms in Systemic Sclerosis Systemic Sclerosis

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 9, 2021

Primary Completion Date

May 15, 2024

Study Completion Date

June 1, 2024

Conditions
Systemic Sclerosis
Interventions
DEVICE

Auricular vagus nerve stimulation

Patients will have 20-minutes stimulation sessions at home twice a day during 3 months.

DEVICE

Sham Auricular vagus nerve stimulation

Patients will have 20-minutes stimulation sessions at home twice a day during 3 months.

Trial Locations (1)

Unknown

vascular medicine department, University hospital, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT04971018 - Impact of Transcutaneous Auricular Vagus Nerve Stimulation on Digestive Symptoms in Systemic Sclerosis Systemic Sclerosis | Biotech Hunter | Biotech Hunter